Treatment-prognostication-adjustment a new therapeutic idea by analyzing T cell immune checkpoint in tumor microenvironment by algorithm: A bibliometric analysis

References

• Pages F, Galon J, Dieu-Nosjean MC, Tartour E, Sautes-Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2010;29(8):1093–16. doi:10.1038/onc.2009.416.
   PubMed Web of Science ®Google Scholar
• Pietras K, Ostman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res. 2010;316(8):1324–31. doi:10.1016/j.yexcr.2010.02.045.
   PubMed Web of Science ®Google Scholar
• Bebis G, Levy D, Rockne R, Lima E, Benos PV. Editorial: advances in mathematical and computational Oncology. Front Physiol. 2022;13:889198. doi:10.3389/fphys.2022.889198.
   PubMed Web of Science ®Google Scholar
• Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904–12. doi:10.1038/onc.2008.271.
   PubMed Web of Science ®Google Scholar
• Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348(6230):74–80. doi:10.1126/science.aaa6204.
   PubMed Web of Science ®Google Scholar
• Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor - host cell communication. Differentiation. 2002;70(9–10):561–73. doi:10.1046/j.1432-0436.2002.700909.x.
   PubMed Web of Science ®Google Scholar
• Budhu A, Forgues M, Ye QH, Jia H-L, He P, Zanetti KA, Kammula US, Chen Y, Qin L-X, Tang Z-Y, et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell. 2006;10(2):99–111. doi:10.1016/j.ccr.2006.06.016.
   PubMed Web of Science ®Google Scholar
• Leone RD, Powell JD. Metabolism of immune cells in cancer. Nat Rev Cancer. 2020;20(9):516–31. doi:10.1038/s41568-020-0273-y.
   PubMed Web of Science ®Google Scholar
• Arneth B. Tumor microenvironment. Med (Kaunas). 2019;56(1):15. doi:10.3390/medicina56010015.
   PubMed Web of Science ®Google Scholar
• Jiang D, Wu X, Sun X, Tan W, Dai X, Xie Y, Du A, Zhao Q. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11. J Nanobiotechnol. 2022;20(1):29. doi:10.1186/s12951-021-01206-7.
   PubMed Web of Science ®Google Scholar
• Zhang H, Dai Z, Wu W, Wang Z, Zhang N, Zhang L, Zeng W-J, Liu Z, Cheng Q. Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer. J Exp Clin Cancer Res. 2021;40(1):184. doi:10.1186/s13046-021-01987-7.
   PubMed Web of Science ®Google Scholar
• Du A, Yang Q, Sun X, Zhao Q. Exosomal circRNA-001264 promotes AML immunosuppression through induction of M2-like macrophages and PD-L1 overexpression. Int Immunopharmacol. 2023;124(Pt A):110868. doi:10.1016/j.intimp.2023.110868.
   PubMedGoogle Scholar
• Nishimura CD, Pulanco MC, Cui W, Lu L, Zang X. PD-L1 and B7-1 Cis-interaction: new mechanisms in immune checkpoints and immunotherapies. Trends Mol Med. 2021;27(3):207–19. doi:10.1016/j.molmed.2020.10.004.
   PubMed Web of Science ®Google Scholar
• Mulet-Forteza C, Lunn E, Merigó JM, Horrach P. Research progress in tourism, leisure and hospitality in Europe (1969–2018). Int J Contemp Hosp Manage. 2021;33(1):48–74. doi:10.1108/IJCHM-06-2020-0521.
   Web of Science ®Google Scholar
• Ke L, Lu C, Shen R, Lu T, Ma B, Hua Y. Knowledge mapping of drug-induced liver injury: a scientometric investigation (2010-2019). Front Pharmacol. 2020;11:842. doi:10.3389/fphar.2020.00842.
   PubMed Web of Science ®Google Scholar
• Devos P, Ménard J. Trends in worldwide research in hypertension over the period 1999-2018: a bibliometric study. Hypertension. 2020;76(5):1649–55. doi:10.1161/HYPERTENSIONAHA.120.15711.
   PubMed Web of Science ®Google Scholar
• Chen C, Song M, Glanzel W. Visualizing a field of research: a methodology of systematic scientometric reviews. PloS One. 2019;14(10):e0223994. doi:10.1371/journal.pone.0223994.
   PubMed Web of Science ®Google Scholar
• Ma C, Su H, Li H. Global research trends on prostate diseases and erectile dysfunction: a bibliometric and visualized study. Front Oncol. 2020;10:627891. doi:10.3389/fonc.2020.627891.
   PubMed Web of Science ®Google Scholar
• Chen C, Lou Y, Li XY, Lv ZT, Zhang LQ, Mao W. Mapping current research and identifying hotspots on mesenchymal stem cells in cardiovascular disease. Stem Cell Res Ther. 2020;11(1):498. doi:10.1186/s13287-020-02009-7.
   PubMed Web of Science ®Google Scholar
• Huang X, Fan X, Ying J, Chen S. Emerging trends and research foci in gastrointestinal microbiome. J Transl Med. 2019;17(1):67. doi:10.1186/s12967-019-1810-x.
   PubMedGoogle Scholar
• Mulet-Forteza C, Genovart-Balaguer J, Mauleon-Mendez E, Merigó JM. A bibliometric research in the tourism, leisure and hospitality fields. J Bus Res. 2019;101:819–27. doi:10.1016/j.jbusres.2018.12.002.
   Web of Science ®Google Scholar
• Zhu X, Kong Q, Niu X, Chen L, Ge C. Mapping intellectual structure and research performance for the nanoparticles in pancreatic cancer field. Int J Nanomed. 2020;15: 5503–16. 10.2147/IJN.S253599.
   PubMed Web of Science ®Google Scholar
• Zhang XL, Zheng Y, Xia ML, Wu Y-N, Liu X-J, Xie S-K, Wu Y-F, Wang M. Knowledge domain and emerging trends in vinegar research: a bibliometric review of the literature from WoSCC. Foods. 2020;9(2):166. doi:10.3390/foods9020166.
   PubMed Web of Science ®Google Scholar
• Chen L, Ma S, Hu D, Lin H, Zhu Y, Chen K, Chen L, Zheng C, Liu J, Liao Y, et al. Bibliometric study of sodium glucose cotransporter 2 inhibitors in cardiovascular research. Front Pharmacol. 2020;11:561494. doi:10.3389/fphar.2020.561494.
   PubMed Web of Science ®Google Scholar
• Merigó JM, Mulet-Forteza C, Valencia C, Lew AA. Twenty years of tourism geographies: a bibliometric overview. Tourism Geogr. 2019;21(5):881–910. doi:10.1080/14616688.2019.1666913.
   Web of Science ®Google Scholar
• Qin Y, Zhang Q, Liu Y. Analysis of knowledge bases and research focuses of cerebral ischemia-reperfusion from the perspective of mapping knowledge domain. Brain Res Bull. 2020;156:15–24. doi:10.1016/j.brainresbull.2019.12.004.
   PubMed Web of Science ®Google Scholar
• van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–38. doi:10.1007/s11192-009-0146-3.
   PubMed Web of Science ®Google Scholar
• Paunkov A, Chartoumpekis DV, Ziros PG, Sykiotis GP. A bibliometric review of the Keap1/Nrf2 pathway and its related antioxidant compounds. Antioxid (Basel). 2019;8(9):353. doi:10.3390/antiox8090353.
   PubMedGoogle Scholar
• Gao Y, Shi S, Ma W, Chen J, Cai Y, Ge L, Li L, Wu J, Tian J. Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer. Int Immunopharmacol. 2019;72:374–84. doi:10.1016/j.intimp.2019.03.045.
   PubMed Web of Science ®Google Scholar
• Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A. 2004;101 Suppl 1(Suppl 1):5303–10. doi:10.1073/pnas.0307513100.
   PubMed Web of Science ®Google Scholar
• Mulet-Forteza C, Genovart-Balaguer J, Merigó JM, Mauleon-Mendez E. Bibliometric structure of IJCHM in its 30 years. Int J Contemp Hosp Manage. 2019;31(12):4574–604. doi:10.1108/IJCHM-10-2018-0828.
   Web of Science ®Google Scholar
• Chen C, Leydesdorff L. Patterns of connections and movements in dual-map overlays: a new method of publication portfolio analysis. J Assoc Inf Sci Technol. 2014;65(2):334–51. doi:10.1002/asi.22968.
   Web of Science ®Google Scholar
• Chen C, Hu Z, Liu S, Tseng H. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert Opin Biol Ther. 2012;12(5):593–608. doi:10.1517/14712598.2012.674507.
   PubMed Web of Science ®Google Scholar
• Chen C. Science mapping: a systematic review of the literature. J Data Inf Sci. 2017;2(2):1–40. doi:10.1515/jdis-2017-0006.
   Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. doi:10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Shetty S, Idell S. Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro. Mol Cell Biochem. 1999;199(1–2):189–200. doi:10.1023/A:1006914800447.
   PubMed Web of Science ®Google Scholar
• Morawski K, Gabriel A, Namyslowski G, Ziólkowski A, Pietrawska V, Steplewska K. Clinical application of proliferating cell nuclear antigen, oncoprotein p53 and tumor front grading analysis in patients operated on for laryngeal cancer. Eur Arch Otorhinolaryngol. 1999;256(8):378–83. doi:10.1007/s004050050168.
   PubMed Web of Science ®Google Scholar
• Czekay RP, Cheon DJ, Samarakoon R, Kutz SM, Higgins PJ. Cancer-associated fibroblasts: mechanisms of tumor progression and novel therapeutic targets. Cancers. 2022;14(5):29. doi:10.3390/cancers14051231.
   Web of Science ®Google Scholar
• Shum B, Larkin J, Turajlic S. Predictive biomarkers for response to immune checkpoint inhibition. Semin Cancer Biol. 2022;79:4–17. doi:10.1016/j.semcancer.2021.03.036.
   PubMed Web of Science ®Google Scholar
• Yang KY, Wu ZJ, Zhang H, Zhang N, Wu W, Wang Z, Dai Z, Zhang X, Zhang L, Peng Y, et al. Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer. 2022;21(1):32. doi:10.1186/s12943-022-01513-z.
   PubMed Web of Science ®Google Scholar
• Kodonas K, Fardi A, Gogos C, Economides N. Scientometric analysis of vital pulp therapy studies. Int Endod J. 2021;54(2):220–30. doi:10.1111/iej.13422.
   PubMed Web of Science ®Google Scholar
• Liang YD, Li Y, Zhao J, Wang XY, Zhu HZ, Chen XH. Study of acupuncture for low back pain in recent 20 years: a bibliometric analysis via CiteSpace. J Pain Res. 2017;10:951–64. doi:10.2147/JPR.S132808.
   PubMed Web of Science ®Google Scholar
• Xiao F, Li C, Sun J, Zhang L. Knowledge domain and emerging trends in organic photovoltaic technology: a scientometric review based on citespace analysis. Front Chem. 2017;5:67. doi:10.3389/fchem.2017.00067.
   PubMed Web of Science ®Google Scholar
• Liu G, Jiang R, Jin Y. Sciatic nerve injury repair: a visualized analysis of research fronts and development trends. Neural Regen Res. 2014;9(18):1716–22. doi:10.4103/1673-5374.141810.
   PubMed Web of Science ®Google Scholar
• Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood. 2006;107(5):1761–7. doi:10.1182/blood-2005-08-3182.
   PubMed Web of Science ®Google Scholar
• Woo SR, Fuertes MB, Corrales L, Spranger S, Furdyna M, Leung MK, Duggan R, Wang Y, Barber G, Fitzgerald K, et al. Sting-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity. 2014;41(5):830–42. doi:10.1016/j.immuni.2014.10.017.
   PubMed Web of Science ®Google Scholar
• Zeng DQ, Li MY, Zhou R, Zhang J, Sun H, Shi M, Bin J, Liao Y, Rao J, Liao W, et al. Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures. Cancer Immunol Res. 2019;7(5):737–50. doi:10.1158/2326-6066.CIR-18-0436.
   PubMed Web of Science ®Google Scholar
• Disis ML. Immune regulation of cancer. J Clin Oncol. 2010;28(29):4531–8. doi:10.1200/JCO.2009.27.2146.
   PubMed Web of Science ®Google Scholar
• DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, Madden SF, Gallagher WM, Wadhwani N, Keil SD, Junaid SA, et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 2011;1(1):54–67. doi:10.1158/2159-8274.CD-10-0028.
   PubMed Web of Science ®Google Scholar
• Mu CY, Huang JA, Chen Y, Chen C, Zhang XG. High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation. Medical Oncol. 2011;28(3):682–8. doi:10.1007/s12032-010-9515-2.
   PubMed Web of Science ®Google Scholar
• Zhang JP, Yan J, Xu J, Pang X-H, Chen M-S, Li L, Wu C, Li S-P, Zheng L. Increased intratumoral IL-17-producing cells survival in hepatocellular carcinoma correlate with poor patients. J Hepatol. 2009;50(5):980–9. doi:10.1016/j.jhep.2008.12.033.
   PubMed Web of Science ®Google Scholar
• Qian BZ, Li JF, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475(7355):222–U129. doi:10.1038/nature10138.
   PubMed Web of Science ®Google Scholar
• Galand C, Donnou S, Molina TJ, Fridman WH, Fisson S, Sautès-Fridman C. Influence of tumor location on the composition of immune infiltrate and its impact on patient survival. Lessons from DCBCL and animal models. Front Immunol. 2012;3:98. doi:10.3389/fimmu.2012.00098.
   PubMed Web of Science ®Google Scholar
• Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, Sautès-Fridman C, Ma Y, Tartour E, Zitvogel L, et al. Trial watch: prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology. 2012;1(8):1323–43. doi:10.4161/onci.22009.
   PubMed Web of Science ®Google Scholar
• Gao HF, Cheng CS, Tang J, Li Y, Chen H, Meng Z-Q, Chen Z, Chen L-Y. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression. Aging-Us. 2020;12(1):502–17. doi:10.18632/aging.102638.
   Web of Science ®Google Scholar
• Lieber S, Reinartz S, Raifer H, Finkernagel F, Dreyer T, Bronger H, Jansen JM, Wagner U, Worzfeld T, Müller R, et al. Prognosis of ovarian cancer is associated with effector memory CD8 + T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells. Oncoimmunology. 2018;7(5):9. doi:10.1080/2162402X.2018.1424672.
   Web of Science ®Google Scholar
• Razis E, Kalogeras KT, Kotsantis I, Koliou G-A, Manousou K, Wirtz R, Veltrup E, Patsea H, Poulakaki N, Dionysopoulos D, et al. The role of CXCL13 and CXCL9 in early breast cancer. Clin Breast Cancer. 2020;20(1):E36–E53. doi:10.1016/j.clbc.2019.08.008.
   PubMed Web of Science ®Google Scholar
• Singh P, Blatt A, Feld S, Zohar Y, Saadi E, Barki-Harrington L, Hammond E, Ilan N, Vlodavsky I, Chowers Y, et al. The heparanase inhibitor PG545 attenuates colon cancer initiation and growth, associating with increased p21 Expression(1). Neoplasia. 2017;19(3):175–84. doi:10.1016/j.neo.2016.12.001.
   PubMed Web of Science ®Google Scholar
• Chen C, Dubin R, Kim MC. Orphan drugs and rare diseases: a scientometric review (2000 – 2014). Expert Opin Orphan Drugs. 2014;2(7):709–24. doi:10.1517/21678707.2014.920251.
   Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7. doi:10.1038/nmeth.3337.
   PubMed Web of Science ®Google Scholar
• Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, et al. Safety, activity, and immune correlates of anti–PD-1 antibody in cancer. N Engl J Med. 2012;366(26):2443–54. doi:10.1056/NEJMoa1200690.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.20107.
   PubMed Web of Science ®Google Scholar
• Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, Sautès-Fridman C, Ma Y, Tartour E, Zitvogel L, et al. Trial watch prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology. 2012;1(8):1323–43. doi:10.4161/onci.22009.
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–37. doi:10.1038/nm.3394.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. doi:10.3322/caac.21254.
   PubMed Web of Science ®Google Scholar
• Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJM, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. 2014;515(7528):568–71. doi:10.1038/nature13954.
   PubMed Web of Science ®Google Scholar
• Chen C. CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol. 2006;57(3):359–77. doi:10.1002/asi.20317.
   Web of Science ®Google Scholar
• Lu C, Liu M, Shang W, Yuan Y, Li M, Deng X, Li H, Yang K. Knowledge mapping of angelica sinensis (Oliv.) diels (Danggui) research: a scientometric study. Front Pharmacol. 2020;11:294. doi:10.3389/fphar.2020.00294.
   PubMed Web of Science ®Google Scholar
• Li TW, Fu JX, Zeng ZX, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W14. doi:10.1093/nar/gkaa407.
   PubMed Web of Science ®Google Scholar
• Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR, Hunter T, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174–86. doi:10.1038/s41568-019-0238-1.
   PubMed Web of Science ®Google Scholar
• Helmink BA, Reddy SM, Gao JJ, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577(7791):549–55. doi:10.1038/s41586-019-1922-8.
   PubMed Web of Science ®Google Scholar
• Jiang P, Gu SQ, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550–8. doi:10.1038/s41591-018-0136-1.
   PubMed Web of Science ®Google Scholar
• Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747–56. doi:10.1101/gr.239244.118.
   PubMed Web of Science ®Google Scholar
• Yan WT, Lu S, Yang YD, Ning W-Y, Cai Y, Hu X-M, Zhang Q, Xiong K. Research trends, hot spots and prospects for necroptosis in the field of neuroscience. Neural Regen Res. 2021;16(8):1628–37. doi:10.4103/1673-5374.303032.
   PubMed Web of Science ®Google Scholar
• Cajal SRY, Sese M, Capdevila C, Aasen T, De Mattos-Arruda L, Diaz-Cano SJ, Hernández-Losa J, Castellví J. Clinical implications of intratumor heterogeneity: challenges and opportunities. J Mol Med-Jmm. 2020;98(2):161–77. doi:10.1007/s00109-020-01874-2.
   PubMed Web of Science ®Google Scholar
• Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A. Tumour evolution in hepatocellular carcinoma. Nat Rev Gastro Hepat. 2020;17(3):139–52. doi:10.1038/s41575-019-0229-4.
   PubMed Web of Science ®Google Scholar
• Sharonov GV, Serebrovskaya EO, Yuzhakova DV, Britanova OV, Chudakov DM. B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nat Rev Immunol. 2020;20(5):294–307. doi:10.1038/s41577-019-0257-x.
   PubMed Web of Science ®Google Scholar
• Tan AC, Ashley DM, Lopez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA-Cancer J Clin. 2020;70(4):299–312. doi:10.3322/caac.21613.
   PubMed Web of Science ®Google Scholar